Influenza B virus Nucleoprotein antibody
GTX135819
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityVirus
Overview
- SupplierGeneTex
- Product NameInfluenza B virus Nucleoprotein antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:5000-1:110000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- HostRabbit
- IsotypeIgG
- ReactivityVirus
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Myers ML, Gallagher JR, Woolfork DD, et al. Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus. Front Immunol. 2022,13:1002286. doi: 10.3389/fimmu.2022.1002286Read this paper

![ICC/IF analysis of MDCK cells infected with Influenza B virus using GTX00707 Influenza B virus Nucleoprotein antibody [8C8] Upper : The cells infected with an Influenza B virus vaccine strain, Malaysia/2506/2004 as a representative of Victoria group. Lower : The cells infected with an Influenza B virus vaccine strain, Florida/4/2006 as Yamagata group. Fixation : 4% PFA in PBS Permeabilization : 0.1% Triton X-100 in PBS](https://www.genetex.com/upload/website/prouct_img/normal/GTX00707/GTX00707_20191104_ICC-IF_w_23053121_616.webp)